3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
7
Ovarian Neoplasms
4
Neoplasm Metastasis
3
Endometrial Neoplasms
3
Prostatic Neoplasms
2
Multiple Myeloma
2
Mouth Neoplasms
2
Lymphoma
2
Laryngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinoma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms, Unknown Primary
1
Neoplasms
1
Melanoma
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Interventions
enzalutamide
10
Prednisone
6
Docetaxel
5
Abiraterone Acetate
4
darolutamide
3
olaparib
2
niraparib
2
abiraterone
2
Pluvicto
2
zimberelimab
1
xentuzumab
1
sacituzumab govitecan
1
radium Ra 223 dichloride
1
quemliclustat
1
ibrutinib
1
gedatolisib
1
gallium 68 PSMA-11
1
fludrocortisone acetate
1
cabazitaxel
1
TVB-2640
1
Rosuvastatin Calcium
1
Pioglitazone
1
Omeprazole
1
Nivolumab
1
JNJ-64619178
1
JNJ-64264681
1
Ipilimumab
1
Gonadotropin-Releasing Hormone
1
Dexamethasone
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Prostatic Neoplasms, Castration-Resistant
×
ipatasertib
×
1 year
×
Clear all
No trials found.